Small molecule high throughput screen using AstraZeneca facilities

Funding type: Grant · Funders: Medical Research Council (MRC)

MRC ]]>

This opportunity is open to organisations with standard eligibility. Check if your organisation is eligible . Who is eligible to apply To be eligible to apply for this funding opportunity you must show that you will direct the project and be actively engaged in the work. For applicants who do not have a contract of employment for the duration of the proposed project, by submitting an application the research organisation is confirming, if it is successful: • contracts will be extended beyond the end date of the project • all necessary support for the project and the applicants will be provided, including mentorship and career development for early career researchers Demand management You can only submit one application as project lead to this funding opportunity. Resubmissions We will not accept uninvited resubmission of applications that were submitted after 1 April 2026 to Medical Research Council (MRC), the rest of UK Research and Innovation (UKRI) or any other funder. An uninvited resubmission is an application that was previously unsuccessful and has been submitted again without being invited by MRC. This includes applications that are unchanged, minimally revised, or substantially the same as the original submission. Uninvited resubmissions will be rejected. You should contact us if you are unsure whether your application is a resubmission. Find contacts in the ‘contact details’ section. Who is not eligible to apply Research applications that are led by commercial entities are not eligible. Applications may not include collaborations with additional commercial parties. You are also not eligible to apply for this funding opportunity as a project lead if you are based at an international research organisation. This does not include MRC Unit The Gambia or MRC/UVRI Uganda Research Unit at the London School of Hygiene and Tropical Medicine that are eligible to apply as project lead. Equality, diversity and inclusion We are committed to achieving equality of opportunity for all funding applicants. We encourage applications from a diverse range of researchers. We support people to work in a way that suits their personal circumstances. This includes: • career breaks • support for people with caring responsibilities • flexible working • alternative working patterns UKRI can offer disability and accessibility support for UKRI applicants and grant holders during the application and assessment process.

주 대상 국가

🇬🇧 영국

추가 적격 국가

없음

해외기업 지원

확인 필요

현지 법인

확인 필요

지역 조건

영국 소재 기관·기업(또는 영국 파트너와의 협업)이 일반적으로 요구됩니다(원문 확인 필요).

제출서류 정보가 수집되지 않았습니다 (확인 필요). 공식 공고문에서 직접 확인하세요.

신청 절차 정보가 확인되지 않았습니다.

평가 절차 정보가 확인되지 않았습니다.

신청 절차 정보가 확인되지 않았습니다.

Risk 분석 결과가 없습니다. Admin에서 재분석을 실행하세요.

IP 분석 결과가 없습니다.

공식 URL

https://www.ukri.org/opportunity/small-molecule-high-throughput-screen-using-astrazeneca-facilities/

신청 URL

https://www.ukri.org/opportunity/small-molecule-high-throughput-screen-using-astrazeneca-facilities/

최종 수집

2026.09.20

담당자 검수

미검수 (공고 원문 확인 권장)

최초 수집

2026.09.10

데이터 상태

자동 수집 (미검수)

AI 보강

확인 필요